LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4117 | 4513 | 0.9123 | 0.8792 |
MDA-MB-231 | Torin1 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1985 | 4513 | 0.4399 | 0.2286 |
MDA-MB-231 | Torin2 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1291 | 4513 | 0.2860 | 0.0168 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1317 | 4513 | 0.2919 | 0.0248 |
MDA-MB-231 | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1273 | 4513 | 0.2820 | 0.0113 |
MDA-MB-231 | TWS119 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4211 | 4513 | 0.9330 | 0.9078 |
MDA-MB-231 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4648 | 4513 | 1.0299 | 1.0412 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4923 | 4513 | 1.0907 | 1.1249 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4250 | 4513 | 0.9416 | 0.9196 |
MDA-MB-231 | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1684 | 4513 | 0.3732 | 0.1368 |
MDA-MB-231 | WZ3105 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 471 | 4513 | 0.1044 | -0.2333 |
MDA-MB-231 | XMD11-50 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3405 | 4513 | 0.7544 | 0.6618 |
MDA-MB-231 | Y39983 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3402 | 4513 | 0.7539 | 0.6611 |
MDA-MB-231 | YM 201636 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4204 | 4513 | 0.9316 | 0.9057 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3522 | 4513 | 0.7804 | 0.6976 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3577 | 4513 | 0.7926 | 0.7144 |
MDA-MB-231 | Sigma A6730 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4453 | 4513 | 0.9866 | 0.9816 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 470 | 4513 | 0.1041 | -0.2337 |
MDA-MB-231 | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 496 | 4513 | 0.1100 | -0.2257 |
MDA-MB-231 | AZD 5438 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1811 | 4513 | 0.4014 | 0.1757 |
MDA-MB-231 | AZD-6482 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3974 | 4513 | 0.8806 | 0.8356 |
MDA-MB-231 | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1162 | 4513 | 0.2574 | -0.0226 |
MDA-MB-231 | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1857 | 4513 | 0.4115 | 0.1896 |
MDA-MB-231 | AZD8330 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1404 | 4513 | 0.3111 | 0.0513 |
MDA-MB-231 | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1541 | 4513 | 0.3416 | 0.0933 |